|Articles|November 6, 2017

Bioclinica Acquires MDDX Research & Informatics

Bioclinica® announced it has acquired Silicon Valley-based MDDX Research & Informatics, adding advanced cloud research image management and submission technologies to its extensive suite of eHealth solutions. This new acquisition will become the backbone of Bioclinica's SMART solution and will advance the image submission process for clinical research sites.

Read the full release here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

Bioclinica Acquires MDDX Research & Informatics

Related Content

Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV

Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad

ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced

The CRA of the Future: From Monitoring Activity to Strategic Site Partnership

Data Quality Across the Clinical Trial Lifecycle: What It Takes to Fully Trust Your Data

Trending on Applied Clinical Trials Online

ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced

Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad

Breaking the Efficacy Ceiling in IBD and Beyond

Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program

ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps